(Q52892524)

9 May 2018

title

Expression of pro-inflammatory cytokines by TCR alpha beta+ and TCR gamma delta+ T cells in an experimental model of colitis. (English)

1 reference

9 May 2018

author name string

Simpson SJ

1

1 reference

9 May 2018

Holländer GA

2

1 reference

9 May 2018

Mizoguchi E

3

1 reference

9 May 2018

Allen D

4

1 reference

9 May 2018

Bhan AK

5

1 reference

9 May 2018

Wang B

6

1 reference

9 May 2018

Terhorst C

7

1 reference

9 May 2018

language of work or name

English

0 references

publication date

1 January 1997

1 reference

9 May 2018

European Journal of Immunology

published in

1 reference

9 May 2018

volume

27

1 reference

9 May 2018

issue

1

1 reference

9 May 2018

page(s)

17-25

1 reference

9 May 2018

Inflammatory bowel disease (1)

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270104

7 January 2021

Inflammatory bowel disease (2)

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270104

7 January 2021

T cells in inflammatory bowel disease: protective and pathogenic roles.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270104

7 January 2021

A block in both early T lymphocyte and natural killer cell development in transgenic mice with high-copy numbers of the human CD3E gene

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270104

7 January 2021

Over-expression of CD3 epsilon transgenes blocks T lymphocyte development.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270104

7 January 2021

Developmental control point in induction of thymic cortex regulated by a subpopulation of prothymocytes.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270104

7 January 2021

Severe colitis in mice with aberrant thymic selection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270104

7 January 2021

Natural killer cell development is blocked in the context of aberrant T lymphocyte ontogeny

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270104

7 January 2021

A monoclonal antibody to murine CD45R distinguishes CD4 T cell populations that produce different cytokines

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270104

7 January 2021

CD4+ T cells that express high levels of CD45RB induce wasting disease when transferred into congenic severe combined immunodeficient mice. Disease development is prevented by cotransfer of purified CD4+ T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270104

7 January 2021

Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270104

7 January 2021

Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270104

7 January 2021

Inhibition of Thl responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270104

7 January 2021

The expanding universe of T-cell subsets: Th1, Th2 and more.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270104

7 January 2021

Interleukin-10-deficient mice develop chronic enterocolitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270104

7 January 2021

T helper cell 1-type CD4+ T cells, but not B cells, mediate colitis in interleukin 10-deficient mice.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270104

7 January 2021

Mutations in T-cell antigen receptor genes alpha and beta block thymocyte development at different stages

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270104

7 January 2021

Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270104

7 January 2021

Evidence that CD4+, but not CD8+ T cells are responsible for murine interleukin‐2‐deficient colitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270104

7 January 2021

Differential production of interferon-γ and interleukin-4 in response to Th1- and Th2-stimulating pathogens by γδ T cells in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270104

7 January 2021

The extrathymic T-cell development pathway

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270104

7 January 2021

T cells, but not B cells, are required for bowel inflammation in interleukin 2-deficient mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270104

7 January 2021

Cytokine imbalance and autoantibody production in T cell receptor-alpha mutant mice with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270104

7 January 2021

A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270104

7 January 2021

Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270104

7 January 2021

Identifiers

DOI

10.1002/EJI.1830270104

1 reference

9 May 2018

1 reference

9 May 2018